ÂÜÀòÂÒÂ×

Brendan Magrab (CEO) has more than 25 years of experience in pharmaceutical development and marketing. He was most recently President of Transpharmative Advisors. Before that he was President and Chief Executive Officer of URL Pharma, Inc., where he had held positions of increasing responsibility, serving as Vice President of Intellectual Property, then General Counsel, and then Executive Vice President of Commercial Operations. He was Vice President of Intellectual Property for Alpharma, Inc., and he served as an associate at a Washington DC law firm, as a law clerk for the U.S. Court of Appeals for the Federal Circuit, and as a Patent Examiner at the U.S. Patent and Trademark Office. He served as Chairman of HedgePath Pharmaceuticals, Inc., from November 2016 to June 2019. Mr. Magrab received his Bachelor’s Degree in Biochemistry and Art History from the University of Virginia and his Juris Doctor from Georgetown University Law Center.